Interplay of Non-coding RNAs and Approved Antimetabolites Such As Gemcitabine and Pemetrexed in Mesothelioma

Overview

Journal Noncoding RNA Res

Date 2019 Feb 28

PMID 30809600

Citations 1

Authors

Bernhard Biersack

Affiliations

Soon will be listed here.

Abstract

Gemcitabine and pemetrexed are clinically approved antimetabolites for the therapy of mesothelioma diseases. These drugs are often applied in combination with platinum complexes and other drugs. The activity of antimetabolites depended on the expression levels of certain non-coding RNAs, in particular, of small microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). The development of tumor resistance towards antimetabolites was regulated by non-coding RNAs. An overview of the interplay between gemcitabine/pemetrexed antimetabolites and non-coding RNAs in mesothelioma is provided. Further to this, various non-coding RNA-modulating agents are discussed which displayed positive effects on gemcitabine or pemetrexed treatment of mesothelioma diseases. A detailed knowledge of the connections of non-coding RNAs with antimetabolites will be constructive for the design of improved therapies in future.

Citing Articles

lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.

Chen X, Wang K Med Sci Monit. 2019; 25:8363-8370.

PMID: 31695021 PMC: 6857439. DOI: 10.12659/MSM.918922.

References

Liu P, Liang H, Xia Q, Li P, Kong H, Lei P . Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin Transl Oncol. 2013; 15(9):741-6. DOI: 10.1007/s12094-012-0999-4. View

Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F . New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Front Oncol. 2018; 8:91. PMC: 5891579. DOI: 10.3389/fonc.2018.00091. View

Wang G, Liu G, Ye Y, Fu Y, Zhang X . Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Lett. 2016; 11(4):2661-2667. PMC: 4812513. DOI: 10.3892/ol.2016.4266. View

Xu J, Wang T, Cao Z, Huang H, Li J, Liu W . MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis. Oncotarget. 2014; 5(16):6983-93. PMC: 4196178. DOI: 10.18632/oncotarget.2184. View

Yang C, Yue J, Sims M, Pfeffer L . The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One. 2013; 8(8):e71130. PMC: 3737134. DOI: 10.1371/journal.pone.0071130. View

Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano R, Anant S . Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One. 2012; 7(2):e30590. PMC: 3281833. DOI: 10.1371/journal.pone.0030590. View

Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G . Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila). 2011; 4(10):1698-709. PMC: 3940389. DOI: 10.1158/1940-6207.CAPR-11-0267. View

Henwood J, Brogden R . Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs. 1990; 39(3):438-90. DOI: 10.2165/00003495-199039030-00008. View

Jiang L, Tao C, He A, He X . Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate. World J Surg Oncol. 2014; 12:383. PMC: 4300611. DOI: 10.1186/1477-7819-12-383. View

10.

Huang P, Chubb S, Hertel L, GRINDEY G, Plunkett W . Action of 2',2'-difluorodeoxycytidine on DNA synthesis. Cancer Res. 1991; 51(22):6110-7. View

11.

Tanaka N, Toyooka S, Soh J, Tsukuda K, Shien K, Furukawa M . Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep. 2013; 29(6):2169-74. DOI: 10.3892/or.2013.2351. View

12.

Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M . MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells. 2011; 29(11):1661-71. DOI: 10.1002/stem.741. View

13.

Bao B, Ali S, Ahmad A, Azmi A, Li Y, Banerjee S . Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS One. 2012; 7(12):e50165. PMC: 3521759. DOI: 10.1371/journal.pone.0050165. View

14.

Shan Y, Zhang L, Bao Y, Li B, He C, Gao M . Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J Nutr Biochem. 2012; 24(6):1062-9. DOI: 10.1016/j.jnutbio.2012.08.004. View

15.

Bhattacharya S, Ahir M, Patra P, Mukherjee S, Ghosh S, Mazumdar M . PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials. 2015; 51:91-107. DOI: 10.1016/j.biomaterials.2015.01.007. View

16.

Truini A, Coco S, Alama A, Genova C, Sini C, Dal Bello M . Role of microRNAs in malignant mesothelioma. Cell Mol Life Sci. 2014; 71(15):2865-78. PMC: 11114034. DOI: 10.1007/s00018-014-1584-5. View

17.

Jang J, Lee J, Jeon Y, Kim C . Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer. 2013; 13:421. PMC: 3848851. DOI: 10.1186/1471-2407-13-421. View

18.

Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D . Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 2016; 387(10026):1405-1414. DOI: 10.1016/S0140-6736(15)01238-6. View

19.

Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F . MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol. 2009; 42(3):312-9. DOI: 10.1165/rcmb.2009-0060OC. View

20.

An I, An S, Park S, Lee S, Bae S . Involvement of microRNAs in epigallocatechin gallate-mediated UVB protection in human dermal fibroblasts. Oncol Rep. 2012; 29(1):253-9. DOI: 10.3892/or.2012.2083. View